Thrombosis on a mechanical mitral valve anticoagulated with dabigatran

Journal of Thrombosis and Thrombolysis

Volumn 37, Issue 2, 2014, Pages 84-86

  Coulter, Stephanie ^a   Campos, Karla ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Anticoagulation; Dabigatran; Mechanical valve; Thrombosis

Indexed keywords

DABIGATRAN; WARFARIN;

AGED; ARTICLE; BIOPROSTHETIC MITRAL VALVE; BRAIN SCINTISCANNING; CASE REPORT; CRACKLE; DIASTOLIC HEART MURMUR; DRUG WITHDRAWAL; DYSPNEA; HEART VALVE PROSTHESIS; HOSPITAL ADMISSION; HUMAN; LUNG EDEMA; MALE; MECHANICAL HEART VALVE; MEDICAL HISTORY; MITRAL VALVE REPLACEMENT; PLEURA EFFUSION; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; SUBDURAL HEMATOMA; SURGICAL DRAINAGE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART MURMUR; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VERY ELDERLY;

AGED, 80 AND OVER; ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; HEART VALVE PROSTHESIS; HUMANS; MALE; MITRAL VALVE; THROMBOSIS;

EID: 84894671430     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-0935-7     Document Type: Article

References (17)

1. Roudaut R, Serri K, Lafitte S (2009) Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart 93:137-142
2. Foley PW, Sharma R, Kalra PR (2007) Beware of prosthetic valve thrombosis despite therapeutic anticoagulation. Emerg Med J 24:e18
3. Lengyel M (2008) Diagnosis and treatment of left-sided prosthetic valve thrombosis. Expert Rev Cardiovasc Ther 6:85-93
4. Eriksson BI, Dahl OE, Rosencher N et al (2007) Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 370:949-956
5. Schulman S, Kearon C, Kakkar AK et al (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 364:2342-2352
6. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139-1151
7. Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981-992
8. Redondo S, Martinez MP, Ramajo M, Navarro-Dorado J, Barez A, Tejerina T (2011) Pharmacological basis and clinical evidence of dabigatran therapy. J Hematol Oncol 4:53
9. Van de Werf F, Brueckmann M, Connolly SJ, Friedman J, Granger CB et al (2012) A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: the randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN). Am Heart J 163:931-937
10. US Food and Drug Administration (2012) FDA drug safety communication: Pradaxa (dabigatran etexiliate mesylate) should not be used in patients with mechanical prosthetic heart valves. US Department of Health and Human Services. www.fda.gov/Drugs/DrugSafety/ucm332912.htm. Accessed 10 April 2013
11. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, EM PL, Warfarin Reversal Consensus Group (2004) Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 181:492-497
12. Dittus C, Ansell J (2013) The evolution of oral anticoagulant therapy. Prim Care 40:109-1034
13. Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European society of cardiology. Eur Heart J 28:230-268
14. Salem DN, O'Gara PT, Madias C, Pauker SG, American College of Chest Physicians (2008) Valvular and structural heart disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133(6 Suppl):593S-629S
15. Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol 52:e1-e142
16. Prince J, Hynes M, Labinaz M, Ruel M, Boodhwani M (2012) Mechanical valve thrombosis with dabigatran. J Am Coll Cardiol 60:1710-1711
17. Stewart RA, Astell H, Young L, White HD (2012) Thrombosis on a mechanical aortic valve whilst anticoagulated with dabigatran. Heart Lung Circ 21:53-55